You have 1 action to finish to complete your account. Customize your experience by selecting your interests on the Personalization page
No matches
Gastroenterology

World Digestive Health Day 2024 | May 29

In recognition of World Digestive Health Day, ADVENT is providing medical education resources to increase awareness of eosinophilic esophagitis (EoE).

Ikuo Hirano
MD
Ikuo Hirano
Past event
29May2024

Learning objectives

  • Recognize the importance of long-term monitoring and management to positively impact patient burden in EoE
  • Utilize various tools to comprehensively monitor disease status and impact of chronic type 2 inflammation in patients with EoE

Description

In recognition of World Digestive Health Day, ADVENT will be working to increase awareness of eosinophilic esophagitis (EoE) by providing medical education resources. Discover more about the latest advances in the science of type 2 inflammation and explore how the latest scientific advances may help clinicians improve the quality of life of their patients with EoE. 

Tags
endoscopylong-termmultidisciplinary caremonitoring
MAT-GLB-2401309 - 1.0 - 04/2024; MAT-US-2403359 v1.0 - P Exp. Date: 04/05/2026

Speaker

Gastroenterology

Ikuo Hirano

MD

Professor of Medicine | Northwestern University Feinberg School of Medicine, Chicago, Illinois, United States

See author’s profile
Ikuo Hirano

Related resources

EoE Burden and Pathophysiology of Type 2 Inflammation
Gastroenterology
videoanimation

EoE Burden and Pathophysiology of Type 2 Inflammation

Assessing EoE: Using Endoscopic Features to Assess Disease Status
Gastroenterology
expert video

Assessing EoE: Using Endoscopic Features to Assess Disease Status

Importance of Monitoring and Maintenance in EoE
Gastroenterology
Infographic

Importance of Monitoring and Maintenance in EoE

ADVENT is a global medical education non-promotional program by Sanofi and Regeneron. This website is intended only for duly authenticated healthcare professionals in Argentina, Australia, Austria, Bahrain, Belgium, Brazil, Bulgaria, Canada, Chile, China, Colombia, Costa Rica, Croatia, Czech Republic, Denmark, Dominican Republic, Ecuador, Egypt, Estonia, Finland, France, Germany, Greece, Guatemala, Hong Kong, Hungary, Iceland, India, Israel, Italy, Japan, Kuwait, Latvia, Lebanon, Lithuania, Macau, Malaysia, Norway, Oman, Panama, Peru, Poland, Portugal, Qatar, Romania, Saudi Arabia, Singapore, Slovenia, South Africa, South Korea, Spain, Sudan, Sweden, Switzerland, Taiwan, Thailand, The Netherlands, Turkey, United Arab Emirates, or the United States of America.

Sanofi | Regeneron Logo

© 2024 Sanofi and Regeneron Pharmaceuticals, Inc.

All rights reserved.
MAT-GLB-2302957 v3.0 11/2023

All Rights Reserved.

Sanofi and Regeneron are global leaders in pharmaceutical development, each with a long history of supporting frontline physicians to improve human health and reduce the burden of disease. Driven by the same commitment to patients and their families, Sanofi and Regeneron have partnered to take on type 2 inflammation and the range of chronic conditions in which excessive inflammation plays a role.

Country/region: ArgentinaChange country/region